Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ILMN – Illumina, Inc.

Illumina, Inc.
ILMN
$70.97
Name : Illumina, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $11,241,648,128.00
EPSttm : -7.69
finviz dynamic chart for ILMN
Illumina, Inc.
$70.97
6.99%
$5.33

Float Short %

3.8

Margin Of Safety %

-4

Put/Call OI Ratio

0.67

EPS Next Q Diff

0.25

EPS Last/This Y

12.19

EPS This/Next Y

0.62

Price

76.23

Target Price

122.05

Analyst Recom

2.33

Performance Q

-45.14

Relative Volume

1.66

Beta

1.3

Ticker: ILMN




22 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-03-11ILMN84.280.680.7247770
2025-03-12ILMN84.170.670.5949469
2025-03-13ILMN84.060.660.4949984
2025-03-14ILMN85.550.660.4949934
2025-03-17ILMN85.670.670.8046068
2025-03-18ILMN85.130.660.3546883
2025-03-19ILMN84.960.641.0348068
2025-03-20ILMN84.830.641.7148278
2025-03-21ILMN87.870.620.4447834
2025-03-24ILMN88.060.660.4640090
2025-03-25ILMN87.510.670.4741334
2025-03-26ILMN82.80.660.6542540
2025-03-27ILMN82.280.663.0743949
2025-03-28ILMN79.990.661.2044344
2025-03-31ILMN79.330.660.9839705
2025-04-01ILMN78.250.653.5540625
2025-04-02ILMN81.820.651.6441018
2025-04-03ILMN76.370.673.7842471
2025-04-04ILMN74.080.694.6543209
2025-04-07ILMN73.430.751.0140757
2025-04-08ILMN70.360.742.5641554
2025-04-09ILMN76.220.671.8941213
DateSymbolLastP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-03-11ILMN84.48956.62064.04.51
2025-03-12ILMN84.20948.42076.34.51
2025-03-13ILMN84.05948.42078.14.51
2025-03-14ILMN85.60944.92088.34.51
2025-03-17ILMN85.68944.92072.64.51
2025-03-18ILMN85.13944.92066.04.51
2025-03-19ILMN84.96944.92069.64.51
2025-03-20ILMN84.79944.92069.94.51
2025-03-21ILMN87.65944.92102.04.51
2025-03-24ILMN88.02944.92075.54.51
2025-03-25ILMN87.53944.92066.74.51
2025-03-26ILMN82.83944.92023.34.51
2025-03-27ILMN82.28944.92065.84.51
2025-03-28ILMN80.00944.92046.94.51
2025-03-31ILMN79.34944.92064.44.51
2025-04-01ILMN78.39940.82061.14.51
2025-04-02ILMN81.88940.82111.44.51
2025-04-03ILMN76.42940.82012.04.51
2025-04-04ILMN74.17940.42045.54.50
2025-04-07ILMN73.43940.42063.04.50
2025-04-08ILMN70.30940.42033.74.50
2025-04-09ILMN76.23940.42146.14.50
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-03-11ILMN0.007.874.08
2025-03-12ILMN0.007.874.13
2025-03-13ILMN0.007.874.13
2025-03-14ILMN0.007.874.13
2025-03-17ILMN0.007.864.13
2025-03-18ILMN0.007.864.13
2025-03-19ILMN0.007.864.13
2025-03-20ILMN0.007.864.13
2025-03-21ILMN0.007.864.13
2025-03-24ILMN0.007.854.13
2025-03-25ILMN0.007.854.13
2025-03-26ILMN0.007.853.71
2025-03-27ILMN0.007.853.71
2025-03-28ILMN0.007.853.71
2025-03-31ILMN0.007.843.71
2025-04-01ILMN0.007.843.71
2025-04-02ILMN0.007.843.71
2025-04-03ILMN0.007.843.71
2025-04-04ILMN0.007.843.71
2025-04-07ILMN0.007.843.80
2025-04-08ILMN0.007.843.80
2025-04-09ILMN0.007.843.80
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

0.86

Avg. EPS Est. Current Quarter

0.94

Avg. EPS Est. Next Quarter

1.11

Insider Transactions

Institutional Transactions

7.84

Beta

1.3

Average Sales Estimate Current Quarter

1034

Average Sales Estimate Next Quarter

1067

Fair Value

73.32

Quality Score

41

Growth Score

37

Sentiment Score

9

Actual DrawDown %

85.9

Max Drawdown 5-Year %

-86.2

Target Price

122.05

P/E

Forward P/E

15.07

PEG

P/S

2.76

P/B

5.11

P/Free Cash Flow

17.05

EPS

-7.72

Average EPS Est. Cur. Y​

4.5

EPS Next Y. (Est.)

5.12

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-27.95

Relative Volume

1.66

Return on Equity vs Sector %

-71.2

Return on Equity vs Industry %

-62.3

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

2146.1
Illumina, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 8970
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
stock quote shares ILMN – Illumina, Inc. Stock Price stock today
news today ILMN – Illumina, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ILMN – Illumina, Inc. yahoo finance google finance
stock history ILMN – Illumina, Inc. invest stock market
stock prices ILMN premarket after hours
ticker ILMN fair value insiders trading